David Benedicto
Plus aucun poste en cours
Fortune : 20 $ au 30/04/2024
Historique de carrière de David Benedicto
Anciens postes connus de David Benedicto
Sociétés | Poste | Début | Fin |
---|---|---|---|
DMK PHARMACEUTICALS CORPORATION | Comptroller/Controller/Auditor | 01/12/2014 | 21/07/2023 |
Directeur Financier/CFO | 23/08/2021 | 21/07/2023 | |
BAE Systems, Inc.
BAE Systems, Inc. Information Technology ServicesTechnology Services BAE Systems, Inc. provides support and service solutions for defense, intelligence and civilian systems. The firm offers ship repair, maintenance, modernization, conversion and overhaul services for the U.S. Navy, government, commercial and private customers. It operates full-service shipyards in Alabama, Florida, California, Virginia and Hawaii. The company was founded on November 30, 1999 and is headquartered in Arlington, VA. | Comptroller/Controller/Auditor | - | - |
H.E.R.C. PRODUCTS INC. | Comptroller/Controller/Auditor | - | - |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Comptroller/Controller/Auditor | - | - |
Formation de David Benedicto
University of St. La Salle | Undergraduate Degree |
University of Redlands | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 6 |
Philippines | 2 |
Opérationnelle
Comptroller/Controller/Auditor | 4 |
Director of Finance/CFO | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
DMK PHARMACEUTICALS CORPORATION | Health Technology |
H.E.R.C. PRODUCTS INC. | Process Industries |
Entreprise privées | 2 |
---|---|
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Health Technology |
BAE Systems, Inc.
BAE Systems, Inc. Information Technology ServicesTechnology Services BAE Systems, Inc. provides support and service solutions for defense, intelligence and civilian systems. The firm offers ship repair, maintenance, modernization, conversion and overhaul services for the U.S. Navy, government, commercial and private customers. It operates full-service shipyards in Alabama, Florida, California, Virginia and Hawaii. The company was founded on November 30, 1999 and is headquartered in Arlington, VA. | Technology Services |
- Bourse
- Insiders
- David Benedicto
- Expérience